Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.21.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current Assets:    
Cash $ 1,379,926 $ 3,523
Prepaid Expenses 442,885  
Total current assets 1,822,811 3,523
Deferred offering costs   30,000
Cash and Investments held in Trust Account 300,003,041  
Total Assets 301,825,852 33,523
Current liabilities:    
Accrued offering costs and expenses 127,456  
Due to related party
Total current liabilities 127,456 9,284
Deferred underwriting fee 10,500,000  
Warrant liability 5,392,000  
Total liabilities 16,019,456 9,284
Commitments
Common Stock subject to possible redemption, 28,080,639 and no shares at redemption value at March 31, 2021 and December 31, 2020, respectively 280,806,390  
Stockholders’ Equity:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding  
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 2,719,361 and 0 shares issued and outstanding (excluding 28,080,639 and no shares subject to possible redemption) at March 31, 2021 and December 31, 2020, respectively 272  
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 7,500,000 and 7,618,750 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively [1] 750 762
Additional paid-in capital 2,485,527 24,238
Retained earnings (accumulated deficit) 2,513,457 (761)
Total stockholders’ equity 5,000,006 24,239
Total Liabilities and Stockholders’ Equity $ 301,825,852 $ 33,523
[1] Shares at December 31, 2020 included up to 993,750 founder stock subject to forfeiture by the Sponsor if over-allotment option was not exercised in full or in part by the underwriters (see Note 5).